ACTION MEDICAL RESEARCH — grant history
Latest income
£7.8m
Grants listed (FY2025)
15
Listed grants total
£3.2m
Accounts grants total
£3.0m
listed grants reconcile with the accounts totalextracted from its FY2025 accounts
What changed: FY2024 → FY2025
| Change | Grantee | FY2024 | FY2025 |
|---|---|---|---|
| new | Royal Hospital for Children, Glasgow, Department of Paediatric Endocrinology | — | £298k |
| new | University College London, Institute of Child Health | — | £275k |
| new | University of Oxford Department of Paediatrics | — | £275k |
| new | King’s College London, School of Life Course and Population Sciences | — | £245k |
| new | University College London, Developmental Biology and Cancer | — | £240k |
| new | University College London, Institute for Women’s Health | — | £200k |
| new | University College London, Institute of Ophthalmology | — | £200k |
| new | Queen’s University Belfast Northern Ireland Clinical Research Facility | — | £200k |
| not listed | Translational & Clinical Research Institute Newcastle University | £275k | — |
| not listed | Paediatric Neuroimaging Group Oxford University | £275k | — |
| not listed | Centre for Perinatal Research Queen Mary Medical Centre Nottingham | £275k | — |
| not listed | Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham; Department of Endocrinology, Birmingham Women’s and Children’s Hospital | £250k | — |
| not listed | Centre for Adolescent Rheumatology University College London | £243k | — |
| not listed | University of Cambridge Department for Paediatrics | £200k | — |
| not listed | St Mary University Hospital Department of Surgery and Cancer | £200k | — |
| not listed | King’s College London Department of Perinatal Imaging and Health | £200k | — |
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| Royal Hospital for Children, Glasgow, Department of Paediatric Endocrinology | FY2025 | £298k | Duchenne Muscular Dystrophy: Creating a Tool to Predict Spine Fractures in Young People with DMD |
| University College London, Institute of Child Health | FY2025 | £275k | Rasmussen’s Encephalitis: Uncovering early signs and underlying causes of a rare childhood epilepsy with innovative scientific method |
| University of Oxford Department of Paediatrics | FY2025 | £275k | Post-operative pain: Improving the assessment of pain in infants after surgery |
| King’s College London, School of Life Course and Population Sciences | FY2025 | £245k | Preterm birth: Developing cell therapy to treat preterm birth |
| University College London, Developmental Biology and Cancer | FY2025 | £240k | Preterm birth: Understanding the link with fetal anomalies |
| University College London, Institute for Women’s Health | FY2025 | £200k | Brain injury at birth: Can melatonin or cooling help in cases of mild newborn brain injury? |
| University College London, Institute of Ophthalmology | FY2025 | £200k | Blindness: discovering new therapies for optic atrophy |
| Queen’s University Belfast Northern Ireland Clinical Research Facility | FY2025 | £200k | Preventing vision loss by testing strategies to improve glasses wear in children with learning disabilities |
| Newcastle University Centre for Cancer Wolfson Childhood Cancer Research Centre | FY2025 | £200k | T-cell Acute Lymphoblastic Leukaemia: Laboratory testing of new blockers of TALL survival |
| Birmingham Women’s and Children’s NHS Foundation Trust | FY2025 | £200k | Polycystic Ovarian Syndrome (PCOS): A feasibility trial to help design a definitive clinical trial to test the effectiveness of myo-inositol as a treatment for adolescent PCOS |
| University College London Great Ormond Street Institute of Child Health | FY2025 | £200k | Non-Ketotic Hyperglycinemia (NKH): developing new treatments for life limiting inherited metabolic disease |
| University College London | FY2025 | £199k | Viral respiratory infections: finding effective treatment for vulnerable children |
| Imperial College London, Department of CF and Chronic Lung Infection, National Heart and Lung Institute | FY2025 | £199k | Cystic Fibrosis: Understanding outcomes for children with an inconclusive diagnosis of CFSPID |
| University College London, Department of Neuroscience, Physiology and Pharmacology | FY2025 | £198k | Cystic fibrosis: Developing new drug treatments to improve patient outcomes |
| University of Cambridge Cambridge Universities Hospitals NHS Foundation Trust | FY2025 | £115k | Brain injury in newborn babies: improving prediction and diagnosis through a new cot side brain scanner |
| Translational & Clinical Research Institute Newcastle University | FY2024 | £275k | Inborn errors of immunity: improving the outcomes of stem cell transplantation |
| Paediatric Neuroimaging Group Oxford University | FY2024 | £275k | Improving Outcomes from Premature Babies: Can gentle touch reduce pain? |
| Centre for Perinatal Research Queen Mary Medical Centre Nottingham | FY2024 | £275k | Reducing infections from breathing tubes in premature babies |
| Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham; Department of Endocrinology, Birmingham Women’s and Children’s Hospital | FY2024 | £250k | New treatments for rare childhood onset neurological diseases, Niemann-Pick type C1 disease and Wolfram syndrome |
| Centre for Adolescent Rheumatology University College London | FY2024 | £243k | Juvenile systemic lupus erythematosus (JSLE): identifying children at risk of cardiovascular disease |
| University of Cambridge Department for Paediatrics | FY2024 | £200k | Ventilator-associated pneumonia (VAP): Developing a tool to predict lung infections in children who are critically ill |
| St Mary University Hospital Department of Surgery and Cancer | FY2024 | £200k | Respiratory infections: Developing a novel non-invasive breath test to diagnose bacterial chest infections in critically ill children |
| King’s College London Department of Perinatal Imaging and Health | FY2024 | £200k | Neurodevelopmental conditions: A new way to understand social brain processing in autism by combining MRI scanning and virtual reality |
| Zayed Centre for Rare Disease Research University College London | FY2024 | £200k | Epilepsy: Putting the brake on sodium channels |
| King’s College London Department of Psychology | FY2024 | £197k | Epilepsy: Identifying early life predictors of later neurodevelopmental outcomes |
| Royal Veterinary College Department of Comparative Biological Sciences | FY2024 | £196k | Preterm birth: Preventing brain injury with a novel therapy |
| Newcastle University School of Pharmacy | FY2024 | £177k | Cystinosis: engineering new forms of cysteamine to improve palatability and shelf life |
| University College London Great Ormond Street Institute of Child Health | FY2024 | £175k | Histone deacetylase inhibitors and oligonucleotide antisense double treatment for DMD |
| University of Exeter Department of Clinical and Biomedical Sciences | FY2024 | £129k | Developing an effective treatment for neurofibromatosis type 1 |
| National Heart and Lung Institute, Imperial College London and Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London | FY2023 | £268k | Research Training Fellowship at the National Heart and Lung Institute, Imperial College London and Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London |
| Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital; Molecular and Clinical Sciences Research Institute, St George’s University of London | FY2023 | £250k | Research Training Fellowship at the Centre for Paediatric Inherited and Rare Cardiovascular Disease |
| Medicines Discovery Institute and School of Biosciences, Cardiff University | FY2023 | £250k | Developing non-covalent acid ceramidase inhibitors to treat Krabbe disease |
| Dyson School of Design Engineering, Imperial College London; Department of Respiratory Medicine, Sheffield Children’s NHS Foundation Trust | FY2023 | £249k | Overcoming craniofacial abnormalities: Establishing a digital mass customisation design-through-manufacture pipeline for facemasks for children using non-invasive ventilation (NIV) |
| Department of Women’s and Children’s Health, St Thomas’ Hospital, King’s College London | FY2023 | £247k | A randomised controlled trial to assess the optimal management of preterm birth risk secondary to C-section damage |
| Department of Surgical and Interventional Engineering and School of Cancer and Pharmaceutical Sciences, King’s College London | FY2023 | £246k | Targeted gene therapy in diffuse midline glioma using focused ultrasound |
| Department of Maternal and Fetal Medicine, EGA Institute for Women’s Health, University College London | FY2023 | £245k | Cervical human beta defensin 2 (HBD2) gene therapy for the prevention of infection-associated preterm birth and neonatal morbidity |
| Bristol Medical School, University of Bristol | FY2023 | £242k | Generation of personalised Glomspheres from patients with inherited nephrotic syndromes, to repurpose and discover compounds to rescue the disease phenotype |
| Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, Department of Cell and Developmental Biology and Department of Neuroscience, Physiology and Pharmacology, University College London; MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College London | FY2023 | £200k | Understanding the role of vitamin B6 dyshomeostasis in epilepsy disorders |
| Centre for Cell Biology and Cutaneous Research and the School of Engineering and Materials Science, Queen Mary University of London and the Institute of Inflammation and Ageing, University of Birmingham | FY2023 | £200k | Targeting epigenetic gene regulation in epidermolysis bullosa simplex |
| Department of Genetics and Genomic Medicine and Infection Immunity Inflammation, UCL Great Ormond Street Institute of Child Health, University College London; UCL Elizabeth Garrett Anderson Institute for Women’s Health and Division of Surgery and Interventional Science, University College London | FY2023 | £184k | Development of lentiviral in vivo gene therapy for Progressive Familial Intrahepatic Cholestasis type 3 |
| University of Edinburgh, Centre for Genomic and Experimental Medicine, Western General Hospital | FY2023 | £155k | Preclinical testing of allele-specific antisense oligonucleotide (ASO) therapy for a rare neurodevelopmental disorder caused by mutations in EEF1A2 |
| Department of Electronic and Electrical Engineering, Swansea University and the Division of Infection and Immunity, School of Medicine, Cardiff University | FY2023 | £57k | Development of printed biosensors for screening of human cytomegalovirus (HCMV) in newborn babies |
| Radcliffe Department of Medicine, Nuffield Division of Clinical Laboratory Sciences, University of Oxford. | FY2022 | £272k | Lung disease in babies developing gene therapy for lung surfactant deficiency |
| Research Training Fellowship at the Department of Clinical Neurosciences, University of Cambridge and the Department of Paediatric Neurology, Child Development Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust. | FY2022 | £250k | Multiple sclerosis - assessing brain repair in children |
| Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology and the Department of Neuroscience, Physiology and Pharmacology, University College London. | FY2022 | £248k | Epilepsy – gene therapy for severe childhood epilepsy |
| Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London. | FY2022 | £246k | Brain cancer – developing immunotherapy for medulloblastoma and high-grade glioma |
| Human Genetics, Wellcome Sanger Institute, Cambridge and the Department of Paediatrics, Addenbrooke's Hospital, University of Cambridge. | FY2022 | £229k | Developmental disorders – improving genetic diagnosis |
| Department of Metabolism, Digestion and Reproduction, Chelsea and Westminster Hospital Campus, Imperial College London. | FY2022 | £205k | Preterm birth – understanding how labour begins |
| Department of Cell and Developmental Biology, University College London. | FY2022 | £199k | Vici syndrome – developing a potential new drug treatment |
| Research Training Fellowship at the Centre for Perinatal Research, School of Medicine and School of Computer Science, University of Nottingham. | FY2022 | £195k | Premature babies – developing a clinical prediction tool to guide treatment decisions |
| Research Training Fellowship at the Reconstructive Surgery and Regenerative Medicine Research Centre and In Vitro Toxicology Group, Swansea University Medical School, Swansea University. | FY2022 | £189k | Facial disfigurement – investigating the safety and biocompatibility of novel implants |
| MRC Lifecourse Epidemiology Centre, NIHR BRC-supported Clinical Metabolomics Unit, University of Southampton; Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust. | FY2022 | £187k | Vitamin D supplementation during pregnancy and child health |
| Infection, Immunity and Inflammation Research & Teaching Department, Primary ciliary dyskinesia – restoring ciliary function Genetics and Genomic Medicine Research and Teaching Department, Regenerative Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London; Respiratory Sciences, University of Leicester. | FY2022 | £172k | Primary ciliary dyskinesia – restoring ciliary function |
| Developmental Neurosciences and Developmental Biology and Cancer, UCL Great Ormond Street Institute of Child Health, University College London; Computer Science, University College London; Department of Neurosurgery, Great Ormond Street Hospital, London. | FY2022 | £124k | Epilepsy – investigating a new imaging technique to detect brain lesions |
| School of Biomedical Engineering and Imaging Sciences, King's College London; Pediatric Cardiology Department, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds. | FY2022 | £64k | Congenital heart disease – predicting the outcome of surgical reconstruction of the aorta |
| Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Faculty of Medicine, Southampton General Hospital, University of Southampton and the Department of Child Life and Health, University of Edinburgh | FY2021 | £200k | Inflammatory bowel disease – developing simple blood tests to improve diagnosis and treatment |
| Inflammation, Repair and Development Section, National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital and the Department of Bioengineering, Imperial College London | FY2021 | £200k | Asthma – predicting which pre-school children with wheezing will later develop asthma |
| MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Department of Oncology, and BRC/NHS Translational Molecular Diagnostics Centre, John Radcliffe Hospital, University of Oxford | FY2021 | £185k | Anaemia – understanding the causes of inherited anaemia |
| Department of Infection, Inflammation and Rheumatology and Department of Molecular Immunology, UCL Great Ormond Street Institute of Child Health and the National Amyloidosis Centre, UCL Royal Free Hospital Campus, University College London | FY2021 | £178k | Vasculitis – developing gene therapy for inherited blood vessel inflammation |
| Department of Paediatrics and Department of Medicine, Addenbrookes Hospital, University of Cambridge, Cellular Genetics, Wellcome Sanger Institute, Cambridge, Department of Infectious Diseases and Paediatric Intensive Care Unit, UCL Great Ormond Street Hospital Institute of Child Health, University College London, Institute of Immunology and Immunotherapy and Institute of Inflammation and Ageing, | FY2021 | £174k | COVID-19 – understanding COVID-19 infection in children |
| School of Biomedical Sciences, University of Leeds and Department of Discovery and Translational Science, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds | FY2021 | £144k | Epilepsy – developing treatments for rare, drug-resistant childhood epilepsies |
| Department of Neurosurgery and Department of Paediatric Haematology and Oncology, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, and the NIHR Cambridge Biomedical Research Centre, University of Cambridge, Lancaster Medical School, Faculty of Health and Medicine, Lancaster University and the Children’s Brain Tumour Research Centre, University of Nottingham | FY2021 | £143k | COVID-19 – how has the pandemic affected the diagnosis, treatment and patient experience of children with a newly-diagnosed brain tumour? |
| Department of Women and Children’s Health, St Thomas’ Hospital Campus, King’s College London and Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, Guy’s Hospital, King’s College London | FY2021 | £132k | Preterm birth – developing immunotherapy for prevention of spontaneous preterm birth |
| Neonatal Intensive Care Unit, Rosie Hospital and Department of Neurophysiology, Cambridge University Hospitals NHS Foundation Trust and the Department of Medical Physics and Biomedical Engineering, University College London | FY2021 | £120k | Preterm birth – investigating the importance of sleep cycles on brain development |
| Department of Women and Children’s Health and Department of Perinatal Imaging and Health, King’s College London, Department of Paediatric Neurology, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Trust, Department of Neuroinflammation, Institute of Neurology, University College London and the Neuroimmunology Centre, Great Ormond Street NHS Trust | FY2021 | £100k | Long COVID – understanding how COVID-19 affects the brains of children with persistent symptoms |
| Cancer Comprehensive Centre, Rayne Institute, King’s College London and Precision Medicine, King’s College Hospital | FY2021 | £96k | Diamond-Blackfan anaemia – understanding the causes |
| Paediatric Respiratory Medicine and Paediatric Respiratory Physiotherapy, Royal Brompton Hospital, London, Paediatric and Adolescent Department, University College London Hospitals, Treatment and Rehabilitation for Adolescents and Children with Complex Conditions (TRACCS) Service and Children and Young People’s Psychological Services, University College London Hospitals NHS Foundation Trust, Secti | FY2021 | £91k | Long COVID – developing a new, online treatment programme to address breathing and mental health difficulties |
| Department of Biomedical Imaging Science, University of Leeds, Department of Paediatric Cardiology and Department of Anaesthesia, Leeds General Infirmary, Department of Biomedical Engineering and Evelina Children’s Hospital, King’s College London | FY2021 | £13k | Coarctation of the aorta – making diagnosis earlier |